NL7204972A - - Google Patents

Info

Publication number
NL7204972A
NL7204972A NL7204972A NL7204972A NL7204972A NL 7204972 A NL7204972 A NL 7204972A NL 7204972 A NL7204972 A NL 7204972A NL 7204972 A NL7204972 A NL 7204972A NL 7204972 A NL7204972 A NL 7204972A
Authority
NL
Netherlands
Application number
NL7204972A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7204972A publication Critical patent/NL7204972A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7204972A 1971-04-21 1972-04-13 NL7204972A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13618671A 1971-04-21 1971-04-21
US13818671A 1971-04-21 1971-04-21

Publications (1)

Publication Number Publication Date
NL7204972A true NL7204972A (enExample) 1972-10-24

Family

ID=26834087

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7204972A NL7204972A (enExample) 1971-04-21 1972-04-13

Country Status (4)

Country Link
DE (1) DE2219408A1 (enExample)
FR (1) FR2133979B1 (enExample)
GB (1) GB1356763A (enExample)
NL (1) NL7204972A (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
WO2005113556A1 (en) 2004-05-13 2005-12-01 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
KR20160091440A (ko) 2008-11-13 2016-08-02 길리아드 칼리스토가 엘엘씨 혈액 종양에 대한 요법
BRPI1012333A2 (pt) 2009-03-24 2016-03-29 Gilead Calistoga Llc atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso
AP2011005956A0 (en) 2009-04-20 2011-10-31 Gilead Calistoga Llc Methods of treatment for solid tumors.
CA2768843A1 (en) 2009-07-21 2011-01-27 Gilead Calistoga Llc Treatment of liver disorders with pi3k inhibitors
US8969349B2 (en) * 2010-05-26 2015-03-03 Sunovion Pharmaceuticals Inc. Substituted quinoxalines and quinoxalinones as PDE-10 inhibitors
US8765760B2 (en) * 2011-01-11 2014-07-01 Sunovion Pharmaceuticals, Inc. [1,2,4] triazol [1,5-a] pyrazines useful as inhibitors of phosphodiesterases
NZ629684A (en) 2012-03-05 2016-10-28 Gilead Calistoga Llc Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
WO2015095605A1 (en) 2013-12-20 2015-06-25 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3h) -one
NZ736970A (en) 2013-12-20 2018-11-30 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
MA40059A (fr) 2014-06-13 2015-12-17 Gilead Sciences Inc Inhibiteurs de la phosphatidylinositol 3-kinase
CN111944340B (zh) * 2020-08-21 2022-08-05 无锡市乐卡新材料有限公司 一种耐盐雾防锈涂料

Also Published As

Publication number Publication date
DE2219408A1 (de) 1972-10-26
GB1356763A (en) 1974-06-12
FR2133979A1 (enExample) 1972-12-01
FR2133979B1 (enExample) 1975-10-31

Similar Documents

Publication Publication Date Title
ATA136472A (enExample)
AR196074A1 (enExample)
AU2658571A (enExample)
AU2691671A (enExample)
AU465401B2 (enExample)
AU3005371A (enExample)
AU2941471A (enExample)
AU2894671A (enExample)
AU2742671A (enExample)
AU2726271A (enExample)
AU2564071A (enExample)
AU2684071A (enExample)
AU2485671A (enExample)
AU2952271A (enExample)
AU2684171A (enExample)
AU2836771A (enExample)
AU2930871A (enExample)
AU2486471A (enExample)
AU2588771A (enExample)
AU2654071A (enExample)
AU3038671A (enExample)
AU2669471A (enExample)
AU2473671A (enExample)
AU2940971A (enExample)
AU2456871A (enExample)